Category: Compliance

A Wrong Poison Pill

Delaware Court invalidates Williams’ Poison Pill and finds that Williams’ board has breached its fiduciary duties. What directors and CEOs need to know.

Read More »

Extreme Fighting on Uber’s Board

Uber and investor Goldman Sachs have made a proposal to the board that would reduce Kalanick’s voting power, while expanding the power of new CEO Dara Khosrowshahi in preparation for an initial public offering sometime in the next two years.

Read More »

Boards: Choose a CEO for Long-Term Growth, Not Just a Turnaround

It seems a familiar story these days—a company on rocky ground for a few quarters suddenly finds itself rudderless as the chief executive is let go or departs for greener pastures. In the resulting vacuum, the pressure to make an immediate hire can be intense. But companies are well served to think carefully about whether they truly need a “corporate savior” who can devise and carry out a turnaround strategy in short order, or whether a long-term leader is better suited to lead the company back to market success.

Read More »